CORONA Remedies Limited (NSE:CORONA)
India · Delayed Price · Currency is INR 1,545.30
-34.70 (-2.20%)
At close: Mar 4, 2026
CORONA Remedies Market Cap
CORONA Remedies has a market cap or net worth of 95.72 billion as of March 5, 2026.
Market Cap
95.72B
Enterprise Value
95.80B
Revenue
13.44B
Ranking
n/a
PE Ratio
55.85
Stock Price
1,545.30
Market Cap Chart
Since December 15, 2025, CORONA Remedies's market cap has increased from 87.97B to 95.72B, an increase of 8.80%. That is a compound annual growth rate of 46.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 95.72B | 13.00% |
| Dec 31, 2025 | 84.70B | -3.72% |
| Dec 15, 2025 | 87.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 333.18B |
| AstraZeneca Pharma India | 219.95B |
| Granules India | 142.37B |
| Jubilant Pharmova | 134.45B |
| Rubicon Research | 127.42B |
| Caplin Point Laboratories | 127.32B |
| Sanofi India | 88.93B |
| Viyash Scientific | 87.33B |